As another month ends, the Investing News Network (INN) provides a recap of some of the most critical April developments in the public marijuana space.


The cannabis public sector was all abuzz this past month thanks to two key acquisition plans pushing the boundaries for expectations in the sector.

While merger and acquisition activity has been a consistent trend, the nature of the most recent deals upended some of the previously accepted limitations for players in the industry.

Arguably one of the biggest deals of the year is Canopy Growth’s (NYSE:CGC,TSX:WEED) plan to acquire multi-state operator (MSO) Acreage Holdings (CSE:ACGR.U,OTCQX:ACRGF).

The two marijuana companies agreed to a plan that states Canopy will gain the right to acquire Acreage only when marijuana becomes a legal substance at the federal level in the US.

Acreage shareholders will receive a payment first of US$300 million or US$2.55 per Acreage share. The overall deal is worth US$3.4 billion, according to the two firms.

“When the right is exercised, having access to Canopy Growth’s deep resources will enable us to innovate, develop and distribute quality cannabis brands across the US and continue expanding our US footprint,” Kevin Murphy, president and CEO of Acreage Holdings, said in a press release.

This deal is one of the first agreements under which a publicly traded Canadian producer has announced its intentions to enter the US cannabis market.

The second deal that caught the attention of the market was the planned acquisition of Origin House (CSE:OH,OTCQX:ORHOF) by Cresco Labs (CSE:CL,OTCQX:CRLBF) for C$1.1 billion. That comes to a price point of C$12.38 per share.

“Origin House is one of the only cannabis players that figured this out early and took a pure play approach to the market as a base for national and international expansion,” Charlie Bachtell, CEO of Cresco Labs, said in a press release.

Charles Taerk, president and CEO of Faircourt Asset Management, told INN this move will create the “most dominant” MSO in California, since other MSOs have not placed a “major foothold” in the state yet.

Taerk, who also acts as the sub-advisor to the Ninepoint Alternative Health Fund, said Origin House is one stock that has been misunderstood by investors and has held a top 10 position in his fund.

Watch the video above for more on what happened during the month of April.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Acreage Holdings is a client of the Investing News Network. This article is not paid-for content.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less